José A. Karam

14.4k total citations · 2 hit papers
274 papers, 7.0k citations indexed

About

José A. Karam is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, José A. Karam has authored 274 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Pulmonary and Respiratory Medicine, 129 papers in Molecular Biology and 118 papers in Surgery. Recurrent topics in José A. Karam's work include Renal cell carcinoma treatment (170 papers), Renal and related cancers (96 papers) and Bladder and Urothelial Cancer Treatments (88 papers). José A. Karam is often cited by papers focused on Renal cell carcinoma treatment (170 papers), Renal and related cancers (96 papers) and Bladder and Urothelial Cancer Treatments (88 papers). José A. Karam collaborates with scholars based in United States, Canada and France. José A. Karam's co-authors include Christopher G. Wood, Surena F. Matin, Shahrokh F. Shariat, Nizar M. Tannir, Pheroze Tamboli, Yair Lotan, Eric Jonasch, Pierre I. Karakiewicz, Robert G. Uzzo and Steven C. Campbell and has published in prestigious journals such as New England Journal of Medicine, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

José A. Karam

261 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I

2021 359 citations José A. Karam, Robert G. Uzzo et al. profile →
Epidemiology of Renal Cell Carcinoma: 2022 Update

2022 358 citations Karim Bensalah, José A. Karam et al. European Urology profile →

Peers

José A. Karam

PRM

SURGE

ONCOL

Brian Shuch United States

Gennady Bratslavsky United States

Richard E. Greenberg United States

Jens Bedke Germany

David Y.T. Chen United States

Arnaud Méjean France

A. Ari Hakimi United States

Daniel M. Berney United Kingdom

Aude Fléchon France

Joan Carles Spain

Brian Shuch United States

José A. Karam

5.2k ×1.1

PRM

3.7k ×1.1

1.3k ×0.5

SURGE

2.0k ×1.1

1.4k ×0.9

ONCOL

Citations per year, relative to José A. Karam José A. Karam (= 1×) peers Brian Shuch

Countries citing papers authored by José A. Karam

Since Specialization

Citations

This map shows the geographic impact of José A. Karam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José A. Karam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José A. Karam more than expected).

Fields of papers citing papers by José A. Karam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José A. Karam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José A. Karam. The network helps show where José A. Karam may publish in the future.

Co-authorship network of co-authors of José A. Karam

This figure shows the co-authorship network connecting the top 25 collaborators of José A. Karam. A scholar is included among the top collaborators of José A. Karam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José A. Karam. José A. Karam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alhalabi, Omar, Matthew T. Campbell, Guillermo Alonso, et al.. (2024). Abstract 7523: An integrated analysis of radiologic and pathological responses in patients with metastatic renal cell carcinoma who presented with primary renal tumor in situ and received first-line nivolumab plus ipilimumab followed by cytoreductive nephrectomy. Cancer Research. 84(6_Supplement). 7523–7523.

Abdelsalam, Mohamed E., José A. Karam, Surena F. Matin, et al.. (2023). Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience. Cancers. 15(3). 909–909. 6 indexed citations

Reis, Rodolfo Borges dos, Xiang Shu, Yuanqing Ye, et al.. (2023). Urinary miRNAs Predict Metastasis in Patients With Clinically Localized Clear Cell Renal Cell Carcinoma Treated With Nephrectomy. Clinical Genitourinary Cancer. 22(1). e156–e162.e4. 2 indexed citations

Abdelsalam, Mohamed E., Roland Bassett, José A. Karam, et al.. (2023). Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy. European Urology Open Science. 57. 45–50.

Guo, Tao, Ji Won Hwang, Pheroze Tamboli, et al.. (2021). A generative adversarial approach to facilitate archival-quality histopathologic diagnoses from frozen tissue sections. Laboratory Investigation. 102(5). 554–559. 13 indexed citations

Pieretti, Alberto, Mary E. Westerman, Niki M. Zacharias, et al.. (2021). Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 39(11). 790.e17–790.e23. 5 indexed citations

Zhang, Jinhua, Yuanqing Ye, David W. Chang, et al.. (2018). Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence. American Journal Of Pathology. 188(11). 2487–2496. 36 indexed citations

Meyer, Christian P., Maxine Sun, José A. Karam, et al.. (2017). Complications After Metastasectomy for Renal Cell Carcinoma—A Population-based Assessment. European Urology. 72(2). 171–174. 41 indexed citations

Malouf, Gabriel G., Xiaoping Su, Jianping Zhang, et al.. (2016). DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas. Clinical Cancer Research. 22(24). 6236–6246. 39 indexed citations

10.

Vartolomei, Mihai Dorin, Romain Mathiéu, Vitaly Margulis, et al.. (2016). Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy. World Journal of Urology. 35(1). 121–130. 34 indexed citations

11.

Gu, Jian, Luis A. Herrera, Nizar M. Tannir, et al.. (2015). Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case–Control Study. Clinical Cancer Research. 22(8). 2074–2082. 22 indexed citations

12.

Adibi, Mehrad, Arun Z. Thomas, Leonardo D. Borregales, et al.. (2015). Surgical considerations for patients with metastatic renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 33(12). 528–537. 23 indexed citations

13.

Pal, Sumanta K., Miaoling He, Tommy R. Tong, et al.. (2014). RNA-seq Reveals Aurora Kinase–Driven mTOR Pathway Activation in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma. Molecular Cancer Research. 13(1). 130–137. 37 indexed citations

14.

Ngo, Tin C., Christopher G. Wood, & José A. Karam. (2013). Biomarkers of renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 32(3). 243–251. 37 indexed citations

15.

Sudarshan, Sunil, José A. Karam, James Brugarolas, et al.. (2012). Metabolism of Kidney Cancer: From the Lab to Clinical Practice. European Urology. 63(2). 244–251. 61 indexed citations

16.

Karam, José A., et al.. (2011). Laparoscopic Adrenalectomy for Metachronous Metastases After Ipsilateral Nephrectomy for Renal-Cell Carcinoma. Journal of Endourology. 25(8). 1323–1327. 12 indexed citations

17.

Fan, Jinhai, Jennifer Stanfield, Yi Guo, et al.. (2008). Effect of Trans -2,3-Dimethoxycinnamoyl Azide on Enhancing Antitumor Activity of Romidepsin on Human Bladder Cancer. Clinical Cancer Research. 14(4). 1200–1207. 11 indexed citations

18.

Karam, José A., Yair Lotan, & Shahrokh F. Shariat. (2007). Urine Cytology and Commercially Available Urine-Based Markers for Monitoring of Bladder Urothelial Carcinoma. Laboratory Medicine. 38(1). 48–52. 1 indexed citations

19.

Karam, José A., Yair Lotan, & Shahrokh F. Shariat. (2007). Bladder Cancer Screening and Future Directions in Urine-Based Markers for Bladder Urothelial Carcinoma. Laboratory Medicine. 38(2). 116–120. 1 indexed citations

20.

Karam, José A., Shahrokh F. Shariat, Hong-Ying Huang, et al.. (2007). Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder. Clinical Cancer Research. 13(15). 4400–4406. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact